192 related articles for article (PubMed ID: 19711445)
1. Combined application of high resolution and tandem mass spectrometers to characterize methionine oxidation in a parathyroid hormone formulation.
Pan C; Valente JJ; LoBrutto R; Pickett JS; Motto M
J Pharm Sci; 2010 Mar; 99(3):1169-79. PubMed ID: 19711445
[TBL] [Abstract][Full Text] [Related]
2. Stress degradation studies on lornoxicam using LC, LC-MS/TOF and LC-MSn.
Modhave DT; Handa T; Shah RP; Singh S
J Pharm Biomed Anal; 2011 Nov; 56(3):538-45. PubMed ID: 21757313
[TBL] [Abstract][Full Text] [Related]
3. The application of electrochemistry to pharmaceutical stability testing--comparison with in silico prediction and chemical forced degradation approaches.
Torres S; Brown R; Szucs R; Hawkins JM; Zelesky T; Scrivens G; Pettman A; Taylor MR
J Pharm Biomed Anal; 2015 Nov; 115():487-501. PubMed ID: 26299525
[TBL] [Abstract][Full Text] [Related]
4. LC, LC-MS/TOF and MS(n) studies for the identification and characterization of degradation products of nelfinavir mesylate.
Tiwari RN; Bonde CG
J Pharm Biomed Anal; 2011 Jun; 55(3):435-45. PubMed ID: 21392920
[TBL] [Abstract][Full Text] [Related]
5. A validated stability-indicating RP-HPLC method for levofloxacin in the presence of degradation products, its process related impurities and identification of oxidative degradant.
Lalitha Devi M; Chandrasekhar KB
J Pharm Biomed Anal; 2009 Dec; 50(5):710-7. PubMed ID: 19632800
[TBL] [Abstract][Full Text] [Related]
6. Modes of Degradation and Impurity Characterization in rhPTH (1-34) during Stability Studies.
Kothari R; Kumar V; Jena R; Tunga R; Tunga BS
PDA J Pharm Sci Technol; 2011; 65(4):348-62. PubMed ID: 22293522
[TBL] [Abstract][Full Text] [Related]
7. The use of liquid chromatography-mass spectrometry for the identification of drug degradation products in pharmaceutical formulations.
Wu Y
Biomed Chromatogr; 2000 Oct; 14(6):384-96. PubMed ID: 11002276
[TBL] [Abstract][Full Text] [Related]
8. Drug-excipient compatibility testing-Identification and characterization of degradation products of phenylephrine in several pharmaceutical formulations against the common cold.
Douša M; Gibala P; Havlíček J; Plaček L; Tkadlecová M; Břicháč J
J Pharm Biomed Anal; 2011 Jul; 55(5):949-56. PubMed ID: 21481557
[TBL] [Abstract][Full Text] [Related]
9. A multidisciplinary approach to identify a degradation product in a pharmaceutical dosage form.
Pan C; Guan J; Lin M
J Pharm Biomed Anal; 2011 Mar; 54(4):855-9. PubMed ID: 21129882
[TBL] [Abstract][Full Text] [Related]
10. LC and LC-MS study of stress decomposition behaviour of isoniazid and establishment of validated stability-indicating assay method.
Bhutani H; Singh S; Vir S; Bhutani KK; Kumar R; Chakraborti AK; Jindal KC
J Pharm Biomed Anal; 2007 Mar; 43(4):1213-20. PubMed ID: 17118610
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the degradation products of a color-changed monoclonal antibody: tryptophan-derived chromophores.
Li Y; Polozova A; Gruia F; Feng J
Anal Chem; 2014 Jul; 86(14):6850-7. PubMed ID: 24937252
[TBL] [Abstract][Full Text] [Related]
12. Middle-down fragmentation for the identification and quantitation of site-specific methionine oxidation in an IgG1 molecule.
Pipes GD; Campbell P; Bondarenko PV; Kerwin BA; Treuheit MJ; Gadgil HS
J Pharm Sci; 2010 Nov; 99(11):4469-76. PubMed ID: 20845446
[TBL] [Abstract][Full Text] [Related]
13. Products of Cu(II)-catalyzed oxidation of the N-terminal fragments of alpha-synuclein in the presence of hydrogen peroxide.
Kowalik-Jankowska T; Rajewska A; Jankowska E; Wiśniewska K; Grzonka Z
J Inorg Biochem; 2006 Oct; 100(10):1623-31. PubMed ID: 16839607
[TBL] [Abstract][Full Text] [Related]
14. Methionine, tryptophan, and histidine oxidation in a model protein, PTH: mechanisms and stabilization.
Ji JA; Zhang B; Cheng W; Wang YJ
J Pharm Sci; 2009 Dec; 98(12):4485-500. PubMed ID: 19455640
[TBL] [Abstract][Full Text] [Related]
15. Influence of methionine oxidation on the aggregation of recombinant human growth hormone.
Mulinacci F; Poirier E; Capelle MA; Gurny R; Arvinte T
Eur J Pharm Biopharm; 2013 Sep; 85(1):42-52. PubMed ID: 23958317
[TBL] [Abstract][Full Text] [Related]
16. ESI-MSn and LC-ESI-MS studies to characterize forced degradation products of bosentan and a validated stability-indicating LC-UV method.
Bansal G; Singh R; Saini B; Bansal Y
J Pharm Biomed Anal; 2013 Jan; 72():186-97. PubMed ID: 22999302
[TBL] [Abstract][Full Text] [Related]
17. Methionine oxidation within the cerebroside-sulfate activator protein (CSAct or Saposin B).
Whitelegge JP; Penn B; To T; Johnson J; Waring A; Sherman M; Stevens RL; Fluharty CB; Faull KF; Fluharty AL
Protein Sci; 2000 Sep; 9(9):1618-30. PubMed ID: 11045609
[TBL] [Abstract][Full Text] [Related]
18. Investigation of the pyrolysis products of methionine-enkephalin-Arg-Gly-Leu using liquid chromatography-tandem mass spectrometry.
Meetani MA; Zahid OK; Conlon JM
J Mass Spectrom; 2010 Nov; 45(11):1320-31. PubMed ID: 20967736
[TBL] [Abstract][Full Text] [Related]
19. Residual metals cause variability in methionine oxidation measurements in protein pharmaceuticals using LC-UV/MS peptide mapping.
Zang L; Carlage T; Murphy D; Frenkel R; Bryngelson P; Madsen M; Lyubarskaya Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 May; 895-896():71-6. PubMed ID: 22483985
[TBL] [Abstract][Full Text] [Related]
20. Use of LC-MS/TOF, LC-MS(n), NMR and LC-NMR in characterization of stress degradation products: Application to cilazapril.
Narayanam M; Sahu A; Singh S
J Pharm Biomed Anal; 2015; 111():190-203. PubMed ID: 25890215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
